Voloridge Investment Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,165,043
Closed -$73.2M 1248
2024
Q4
$73.2M Buy
2,165,043
+2,016,795
+1,360% +$68.2M 0.26% 111
2024
Q3
$6.06M Buy
+148,248
New +$6.06M 0.02% 732
2023
Q4
Sell
-433,067
Closed -$15.7M 1282
2023
Q3
$15.7M Sell
433,067
-83,510
-16% -$3.03M 0.08% 341
2023
Q2
$18.4M Sell
516,577
-385,119
-43% -$13.7M 0.09% 308
2023
Q1
$32.1M Buy
901,696
+724,075
+408% +$25.8M 0.16% 191
2022
Q4
$6.24M Sell
177,621
-366,584
-67% -$12.9M 0.03% 575
2022
Q3
$16M Sell
544,205
-394,761
-42% -$11.6M 0.09% 315
2022
Q2
$51.1M Buy
938,966
+754,200
+408% +$41M 0.26% 101
2022
Q1
$10.1M Buy
184,766
+21,174
+13% +$1.15M 0.06% 403
2021
Q4
$9.02M Buy
+163,592
New +$9.02M 0.05% 500
2021
Q2
Sell
-543,186
Closed -$24.2M 1675
2021
Q1
$24.2M Sell
543,186
-214,778
-28% -$9.58M 0.18% 148
2020
Q4
$34.9M Sell
757,964
-86,871
-10% -$4M 0.29% 72
2020
Q3
$39.7M Buy
844,835
+304,457
+56% +$14.3M 0.33% 68
2020
Q2
$27.6M Buy
540,378
+275,956
+104% +$14.1M 0.32% 60
2020
Q1
$12.5M Sell
264,422
-160,982
-38% -$7.62M 0.36% 56
2019
Q4
$25M Buy
425,404
+290
+0.1% +$17K 0.49% 28
2019
Q3
$22.7M Buy
425,114
+237,196
+126% +$12.7M 0.39% 32
2019
Q2
$9.4M Buy
187,918
+153,464
+445% +$7.68M 0.26% 83
2019
Q1
$1.8M Buy
+34,454
New +$1.8M 0.05% 318
2018
Q1
Sell
-273,831
Closed -$12.1M 550
2017
Q4
$12.1M Buy
+273,831
New +$12.1M 0.26% 93
2017
Q3
Sell
-66,452
Closed -$3.58M 437
2017
Q2
$3.58M Buy
+66,452
New +$3.58M 0.09% 219
2017
Q1
Sell
-344,218
Closed -$16.6M 559
2016
Q4
$16.6M Buy
+344,218
New +$16.6M 0.36% 67
2016
Q2
Sell
-287,182
Closed -$14.6M 347
2016
Q1
$14.6M Buy
+287,182
New +$14.6M 0.34% 68
2015
Q4
Sell
-106,167
Closed -$5.1M 233
2015
Q3
$5.1M Buy
+106,167
New +$5.1M 0.24% 108